Concepedia

Yi Wang

YW

15

Publications

850

Citations

14

H-Index

2016

Active since

Affiliations

State Key Laboratory of Oncogene and Related Genes(Current)

Renji Hospital

Shanghai Cancer Institute

Shanghai Jiao Tong University

Soochow University

Yi Wang is an author at State Key Laboratory of Oncogene and Related Genes specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2016–2023

15

Publications

15

Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Xingliang Guo, Hua Jiang, Bizhi Shi et al. · Frontiers in Pharmacology · 2018 · 198 citations · Full text

Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma

Ying Liu, Shengmeng Di, Bizhi Shi et al. · The Journal of Immunology · 2019 · 134 citations

CXCR6 is required for antitumor efficacy of intratumoral CD8<sup>+</sup> T cell

Binglin Wang, Yi Wang, Xiaofan Sun et al. · Journal for ImmunoTherapy of Cancer · 2021 · 97 citations · Full text

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia

Bo Cai, Mei Guo, Yao Wang et al. · Journal of Hematology & Oncology · 2016 · 65 citations · Full text

Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein

Zeyan Pan, Shengmeng Di, Bizhi Shi et al. · Cancer Immunology Immunotherapy · 2018 · 61 citations · Full text

, , +8

Rows per page

1–5 of 15